早期抗生素暴露与低早发型脓毒症风险极早产儿支气管肺发育不良的关联
这项基于中国新生儿协作网(CHNN)2019年1月1日至2021年12月31日前瞻性数据的全国多中心队列研究,纳入胎龄小于32周或出生体重小于1500 g、低早发型脓毒症风险(剖宫产、无产程或胎膜破裂、无绒毛膜羊膜炎临床证据)的极早产儿6510例。生后第一周抗生素暴露分为无暴露(1324例,20.3%)、1–4天(1134例,17.4%)和5–7天(4052例,62.2%)。延长暴露(5–7天)与中重度支气管肺发育不良或死亡风险升高相关(aOR 1.23,95%CI 1.01–1.50),广谱抗生素使用(1–7天)亦与风险升高相关(aOR 1.27,95%CI 1.04–1.55)。作者认为,早期延长或广谱抗生素暴露的极早产儿应监测不良结局。
要点
- 低早发型脓毒症风险的极早产儿中,生后第一周抗生素暴露5–7天者占62.2%(4052/6510),1–4天者占17.4%(1134/6510),无暴露者占20.3%(1324/6510)。
- 延长暴露(5–7天)与中重度支气管肺发育不良或死亡风险升高相关(aOR 1.23,95%CI 1.01–1.50)。
- 广谱抗生素使用(1–7天)与中重度支气管肺发育不良或死亡风险升高相关(aOR 1.27,95%CI 1.04–1.55)。
- 接受抗生素的5186例中,79.0%(4098例)使用广谱抗生素,17.1%(888例)使用窄谱抗生素,3.9%(200例)使用抗真菌药或其他抗生素。
- 作者认为,早期延长或广谱抗生素暴露的极早产儿应监测不良结局。
适用人群与场景
- 胎龄小于32周或出生体重小于1500 g的极早产儿,且低早发型脓毒症风险,定义为剖宫产出生、无产程或胎膜破裂、无绒毛膜羊膜炎临床证据。
- 数据来自中国新生儿协作网(CHNN),2019年1月1日至2021年12月31日前瞻性收集。
诊断标准与关键阈值
- 低早发型脓毒症风险定义:剖宫产出生、无产程或胎膜破裂、无绒毛膜羊膜炎临床证据。
- 早期抗生素暴露定义:生后第一周内抗生素使用的总日历天数,分为无暴露、1–4天暴露和5–7天暴露。
研究设计与关键结果
- 研究类型:全国多中心队列研究,数据来自中国新生儿协作网(CHNN),2019年1月1日至2021年12月31日前瞻性收集。
- 研究人群:CHNN期间共27176例极早产儿(男14874例[54.7%],女12302例[45.3%]),其中6510例(23.9%;男3373例[51.8%],女3137例[48.2%])被归类为低早发型脓毒症风险。
- 暴露分布:低风险极早产儿中,无抗生素暴露1324例(20.3%),1–4天抗生素治疗1134例(17.4%),5–7天抗生素治疗4052例(62.2%)。
- 抗生素类型:接受抗生素的5186例中,广谱抗生素4098例(79.0%),窄谱抗生素888例(17.1%),抗真菌药或其他抗生素200例(3.9%)。
- 主要终点:延长暴露(5–7天)与中重度支气管肺发育不良或死亡风险升高相关(aOR 1.23,95%CI 1.01–1.50)。
- 次要终点:广谱抗生素使用(1–7天)与中重度支气管肺发育不良或死亡风险升高相关(aOR 1.27,95%CI 1.04–1.55)。
证据类型、等级与局限
- 证据类型:全国多中心队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,早期延长或广谱抗生素暴露的极早产儿应监测不良结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: The overutilization of antibiotics in very preterm infants (VPIs) at low risk of early-onset sepsis (EOS) is associated with increased mortality and morbidities. Nevertheless, the association of early antibiotic exposure with bronchopulmonary dysplasia (BPD) remains equivocal.
OBJECTIVE: To evaluate the association of varying durations and types of early antibiotic exposure with the incidence of BPD in VPIs at low risk of EOS.
DESIGN, SETTING, AND PARTICIPANTS: This national multicenter cohort study utilized data from the Chinese Neonatal Network (CHNN) which prospectively collected data from January 1, 2019, to December 31, 2021. VPIs less than 32 weeks' gestational age or with birth weight less than 1500 g at low risk of EOS, defined as those born via cesarean delivery, without labor or rupture of membranes, and no clinical evidence of chorioamnionitis, were included. Data analysis was conducted from October 2022 to December 2023.
EXPOSURE: Early antibiotic exposure was defined as the total number of calendar days antibiotics were administered within the first week of life, which were further categorized as no exposure, 1 to 4 days of exposure, and 5 to 7 days of exposure.
MAIN OUTCOMES AND MEASURES: The primary outcome was the composite of moderate to severe BPD or mortality at 36 weeks' post menstrual age (PMA). Logistic regression was employed to assess factors associated with BPD or mortality using 2 different models.
RESULTS: Of the 27 176 VPIs included in the CHNN during the study period (14 874 male [54.7%] and 12 302 female [45.3%]), 6510 (23.9%; 3373 male [51.8%] and 3137 female [48.2.%]) were categorized as low risk for EOS. Among them, 1324 (20.3%) had no antibiotic exposure, 1134 (17.4%) received 1 to 4 days of antibiotics treatment, and 4052 (62.2%) received 5 to 7 days of antibiotics treatment. Of the 5186 VPIs who received antibiotics, 4098 (79.0%) received broad-spectrum antibiotics, 888 (17.1%) received narrow-spectrum antibiotics, and 200 (3.9%) received antifungals or other antibiotics. Prolonged exposure (5-7 days) was associated with increased likelihood of moderate to severe BPD or death (adjusted odds ratio [aOR], 1.23; 95% CI, 1.01-1.50). The use of broad-spectrum antibiotics (1-7 days) was also associated with a higher risk of moderate to severe BPD or death (aOR, 1.27; 95% CI, 1.04-1.55).
CONCLUSIONS AND RELEVANCE: In this cohort study of VPIs at low risk for EOS, exposure to prolonged or broad-spectrum antibiotics was associated with increased risk of developing moderate to severe BPD or mortality. These findings suggest that VPIs exposed to prolonged or broad-spectrum antibiotics early in life should be monitored for adverse outcomes.
参考来源
- Shi W, Chen Z, Shi L, et al. Early Antibiotic Exposure and Bronchopulmonary Dysplasia in Very Preterm Infants at Low Risk of Early-Onset Sepsis. JAMA Netw Open. 2024. PMID: 38935376. doi:10.1001/jamanetworkopen.2024.18831
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。